Waldkraiburg, Germany

Evgueni Kvassiouk


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Evgueni Kvassiouk: Innovator in Oligonucleotide Conjugates

Introduction

Evgueni Kvassiouk is a notable inventor based in Waldkraiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of oligonucleotide conjugates. His innovative work has led to the development of a unique method that enhances the manufacturing process of these important compounds.

Latest Patents

Kvassiouk holds a patent for a method of manufacturing labeled oligonucleotide conjugates. This invention involves a reaction between an oligonucleotide with a labile protecting group and a labeling compound. The process allows for the partial or complete substitution of the labile protecting group by the labeling compound through a nucleophilic substitution reaction. This advancement is crucial for improving the efficiency and effectiveness of oligonucleotide conjugates in various applications.

Career Highlights

Evgueni Kvassiouk is currently employed at Nimblegen Systems GmbH, where he continues to push the boundaries of innovation in biotechnology. His work at the company has been instrumental in advancing the field and contributing to the development of new technologies.

Collaborations

Kvassiouk collaborates with various professionals in his field, including his coworker Klaus Peter Stengele. These partnerships enhance the research and development efforts at Nimblegen Systems GmbH, fostering an environment of innovation and creativity.

Conclusion

Evgueni Kvassiouk is a prominent figure in the biotechnology sector, recognized for his innovative methods in the manufacturing of oligonucleotide conjugates. His contributions continue to impact the industry positively, showcasing the importance of research and development in advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…